Suppr超能文献

线粒体 KATP 通道通过卡利波肽参与限制梗死面积。

Mitochondrial KATP channels participate in the limitation of infarct size by cariporide.

机构信息

Fellowship of CONICET, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120, 1900, La Plata, Argentina.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2011 Jun;383(6):563-71. doi: 10.1007/s00210-011-0632-z. Epub 2011 Apr 12.

Abstract

The objective of this study is to assess the participation of mitochondrial ATP-sensitive potassium (mitoK(ATP)) channels in the cardioprotective effects of the Na(+)/H(+) exchanger (NHE-1) blocker cariporide in isolated rat hearts. Regional ischemia was induced by occlusion of left anterior descending coronary artery during 40 min followed by 2-h reperfusion (IC). Cariporide (C, 10 μΜ), or C plus 5-hydroxydecanoate (5-HD, 100 μM, a selective mitoK(ATP) channel inhibitor), or C plus chelerythrine (Chele, 1 μM, a PKC inhibitor), or an opener of mitoK(ATP) channels, diazoxide (Dz, 100 μM) was applied at the onset of reperfusion. Infarct size (IS) and myocardial function were evaluated. The calcium-induced permeability transition pore (mPTP) opening was determined by measuring the light scattering decrease (LSD, a.u.) in isolated mitochondria in the absence and presence of C, C + 5-HD and Dz. IS was 33 ± 2% of the risk area in IC and was significantly diminished by C (15 ± 2%, p < 0.05), which also improved myocardial function [LVDP = 58 ± 5% (IC) vs 80 ± 5% (C)] and blunted LSD [0.80 ± 0.04 (IC) vs 0.51 ± 0.04 (C) a.u.]. 5-HD and Chele were both able to abolish the cardioprotective effects of C on IS. Dz treatment decreased IS and LSD to a similar extent to that produced by C (15 ± 4% and 0.52 ± 0.04 a.u., respectively). The present data suggest that attenuation of mPTP opening after PKC-mediated mitoK(ATP) channel activation is a crucial step for the cardioprotective effects of cariporide.

摘要

本研究旨在评估线粒体三磷酸腺苷敏感钾 (mitoK(ATP)) 通道在 Na(+)/H(+) 交换体 (NHE-1) 阻滞剂 cariporide 对分离大鼠心脏的心脏保护作用中的作用。左前降支冠状动脉闭塞 40 分钟后诱发局部缺血,随后进行 2 小时再灌注(IC)。再灌注开始时给予 cariporide (C, 10 μM)、C 加 5-羟癸酸(5-HD,100 μM,选择性 mitoK(ATP) 通道抑制剂)、C 加 chelerythrine(Chele,1 μM,PKC 抑制剂)或 mitoK(ATP) 通道开放剂 diazoxide(Dz,100 μM)。评估梗塞面积(IS)和心肌功能。通过测量无 C、C + 5-HD 和 Dz 时分离线粒体的光散射减少(LSD,a.u.)来确定钙诱导的通透性转换孔(mPTP)开放。IS 为 IC 中风险区域的 33 ± 2%,C 显著降低 IS(15 ± 2%,p < 0.05),还改善了心肌功能[LVDP = 58 ± 5%(IC)与 80 ± 5%(C)],并减轻了 LSD [0.80 ± 0.04(IC)与 0.51 ± 0.04(C)a.u.]。5-HD 和 Chele 均可消除 C 对 IS 的心脏保护作用。Dz 处理降低 IS 和 LSD 的程度与 C 相似(分别为 15 ± 4%和 0.52 ± 0.04 a.u.)。本研究数据表明,PKC 介导的 mitoK(ATP) 通道激活后 mPTP 开放的衰减是 cariporide 心脏保护作用的关键步骤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验